Recent progress in treatment of malignant pleural mesothelioma;Progrès thérapeutiques récents dans le mésothéliome malin primitif de la plèvre

Cancer/Radiotherapie

Volumn 9, Issue 6-7, 2005, Pages 362-365

  Mahe M A ^a   Cellerin, L ^b   Michaud, J L ^b   Sagan, C ^b   Supiot, S ^a   Le Pechoux C ^c  

^a CENTRE RENÉ GAUDUCHEAU   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Chemotherapy; Mesothelioma; Radiotherapy; Surgery

Indexed keywords

CISPLATIN; PEMETREXED;

ADD ON THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER INVASION; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG CARCINOMA; LUNG RESECTION; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURVIVAL RATE;

EID: 28344442102     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2005.09.005     Document Type: Short Survey

References (24)

1. A. Ahamad, C.W. Stevens, W.R. Smythe, A.A. Vaporciyan, R. Komaki, and J.F. Kelly Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma Int. J. Radiat. Oncol. Biol. Phys. 55 2003 768 775
2. J. Aisner Current approaches to malignant mesothelioma of the pleura Chest 107 1995 332S 344S
3. E.H. Baldini, A. Recht, G.M. Strauss, M.M. De Camp Jr., S.J. Swanson, and M.J. Liptay Patterns of failure after trimodality therapy for malignant pleural mesothelioma Ann. Thorac. Surg. 63 1997 334 338
4. A. Banaei, B. Auvert, M. Goldberg, A. Gueguen, D. Luce, and S. Goldberg Future trends in morality of French men from mesothelioma Occup. Environ. Med. 57 2000 488 494
5. T. Berghmans, M. Paesmans, Y. Lalami, I. Louviaux, S. Luce, and C. Mascaux Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis Lung Cancer 38 2002 111 121
6. C. Boutin, F. Rey, and J.R. Viallat Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy Chest 108 1995 754 758
7. L. Cellerin, P. Garry, M.A. Mah́, and E. Chailleux Ḿsoth́liome malin pleural:: radioth́rapie pŕventive des nodules de perḿation Rev. Mal. Respir. 21 2004 53 58
8. K.M. Forster, W.R. Smythe, G. Starkschall, Z. Liao, T. Takanada, and J.F. Kelly Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implantation Int. J. Radiat. Oncol. Biol. Phys. 55 2003 606 616
9. L. Garland, C. Rankin, K. Scott, R. Nagle, M. Lobell, and D. Gandara Molecular correlates of the EGFR signalling pathway in association with SWOG SO218: a phase II study of oral EGFR tyrosine kinase inhibitor OSI-774 in patients with malignant mesothelioma [Abstract] Proc. Am. Soc. Clin. Oncol. 22 2004 196s
10. M. Gross-Goupil, and P. Ruffí Les ḿsoth́liomes malins de la pl̀vre Bull. Cancer 86 1999 46 54
11. B.S. Hilaris, D. Nori, E. Kwong, G.J. Kutcher, and N. Martini Pleurectomy and intraoperative brachytherapy and postoperative radiation in the treatment of malignant pleural mesothelioma Int. J. Radiat. Oncol. Biol. Phys. 10 1984 325 331
12. A.G.S. Ilg, J. Bignon, and A.J. Valleron Estimation of the past and future burden of morality from mesothelioma in France Occup. Environ. Med. 55 1998 760 765
13. T. Keigo, T. Ryosuke, and W. Yoh Surgical approach to pleural diffuse mesothelioma in Japan Lung Cancer 31 2001 57 65
14. L.H. Kindler, T. Karrison, C. Lu, D.R. Gandara, J. Stevenson, and L. Krug A multicenter, double-blind, placebo-controlled randomized phase II trial of gemcitabine-cisplatin (GC) plus bevacizumab (B) or placebo in patients (pts) with malignant mesothelioma (MM) [Abstract] Proc. Am. Soc. Clin. Oncol. 23 2005 625s
15. B.C. Kuenen, L. Rosen, E.F. Smit, M.R.N. Parson, M. Levi, and R. Ruijter Dose finding and pharmacokinetic study of cisplatin, gemcitabine, and SU5416 in patients with solid tumors J. Clin. Oncl. 20 2002 1657 1667
16. o 20.
17. J. Peto, A. Decarli, C. La Vecchia, F. Levi, and E. Negri The European mesothelioma epidemic Br. J. Cancer 79 1999 666 672
18. E. Rosenzweig, V. Gupta, B. Mychalczak, L.M. Krug, R. Flores, and V.W. Rusch Hemithoracic radiation therapy and brachytherapy after pleurectomy-decortication for malignant pleural mesothelioma: results from a 30:year experience [Abstract] Proc. Am. Soc. Clin. Oncol. 23 2005 665s
19. V.W. Rusch, K. Rosenzweig, E. Venkatraman, L. Leon, A. Raben, and L. Harrison A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma J. Thorac. Cardiovasc. Surg. 122 2001 788 795
20. D.J. Sugarbaker, R.M. Flores, M.T. Jaklitsch, W.G. Richards, G.M. Strauss, and J.M. Corson Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: result in 183 patients J. Thorac. Cardiovasc. Surg. 117 1999 54 63
21. J.P. Van Meerbeeck, Manegold, R. Gaafar, R.J. Van Klaveren, M. Vincent, and C. Legrand A randomized phase III study of cisplatin with or without raltitraxed in patients (pts) with malignant pleural mesothelioma (MPM): an intergroup study of the EORTC Lung Cancer Group and NCIC [Abstract] Proc. Am. Soc. Clin. Oncol. 22 2004 622s
22. Villa.
23. J.L. No, H.A. Husain, W.M. Stadler, L.L. Hanson, N.J. Vogelzang, and H.L. Kindler A phase II trial of Imatinib mesylate in patients with malignant mesothelioma [Abstract] Proc. Am. Soc. Clin. Oncol. 22 2004 666s
24. N.J. Vogelzang, J.J. Rusthoven, J. Symanowski, C. Denham, E. Kaukel, and P. Ruffie Phase III study of pemetrexed in combination with malignant pleural mesothelioma J. Clin. Oncol. 21 2003 2636 2644